Lung Cancer: Molecular Mechanisms and Therapeutic Opportunities
Special Issue Editors
Interests: thoracic cancers; head and neck cancers; palliative oncology
Interests: Drug Discovery; Translational Drug Development; Drug Resistance; Early Phase Clinical Trials; Pancreatic Cancer; Gastrointestinal stromal tumor; Lymphoma; Chronic lymphocytic leukemia
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The molecular and cellular understanding of lung cancers has shown rapid evolution leading to new therapies and improved outcomes. Despite the progress and growing science, lung cancer remains the most common cancer worldwide and the most common cause of cancer deaths. Continued improvement in early detection technologies, diagnostic techniques, molecular profiling, and treatment advancements is critical to shift the pendulum in lung cancers.
This Special Issue aims to provide a collection of the current knowledge and advances in the molecular mechanisms of lung cancers, therapeutic opportunities and associated technologies. Reviews and original research articles in experimental studies are welcome.
Dr. Sherri Rauenzahn
Prof. Dr. Daruka Mahadevan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- precision oncology
- immunotherapy
- targeted therapy
- genomic characterization
- biomarker
- microenvironment
- non-small cell lung cancer
- small cell lung cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
